Brief Communication

A more efficient method to generate integration-free human iPS cells

  • Nature Methods volume 8, pages 409412 (2011)
  • doi:10.1038/nmeth.1591
  • Download Citation
Received:
Accepted:
Published online:

Abstract

We report a simple method, using p53 suppression and nontransforming L-Myc, to generate human induced pluripotent stem cells (iPSCs) with episomal plasmid vectors. We generated human iPSCs from multiple donors, including two putative human leukocyte antigen (HLA)-homozygous donors who match 20% of the Japanese population at major HLA loci; most iPSCs are integrated transgene-free. This method may provide iPSCs suitable for autologous and allologous stem-cell therapy in the future.

  • Subscribe to Nature Methods for full access:

    $59

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    , & Nature 448, 313–317 (2007).

  2. 2.

    & Stem Cells 27, 2667–2674 (2009).

  3. 3.

    , , , & Proc. Jpn. Acad. B 85, 348–362 (2009).

  4. 4.

    et al. Nature 458, 766–770 (2009).

  5. 5.

    et al. Nat. Methods 7, 197–199 (2010).

  6. 6.

    et al. Science 324, 797–801 (2009).

  7. 7.

    et al. Cell Stem Cell 4, 472–476 (2009).

  8. 8.

    et al. Cell Stem Cell 7, 618–630 (2010).

  9. 9.

    et al. Nature 460, 1132–1135 (2009).

  10. 10.

    , , , & Proc. Natl. Acad. Sci. USA 107, 14152–14157 (2010).

  11. 11.

    et al. J. Dent. Res. 89, 773–778 (2010).

  12. 12.

    , & Nat. Biotechnol. 26, 739–740 (2008).

  13. 13.

    et al. Proc. Natl. Acad. Sci. USA 107, 12704–12709 (2010).

  14. 14.

    , , & N. Engl. J. Med. 343, 1078–1084 (2000).

  15. 15.

    et al. Hum. Immunol. 68, 491–499 (2007).

  16. 16.

    & Cell 62, 1073–1085 (1990).

  17. 17.

    et al. Cell 131, 861–872 (2007).

  18. 18.

    , & Gene 108, 193–199 (1991).

  19. 19.

    , , , & Science 322, 949–953 (2008).

  20. 20.

    , , , & J. Neurosci. Res. 89, 117–126 (2010).

  21. 21.

    et al. Proc. Natl. Acad. Sci. USA 99, 1580–1585 (2002).

  22. 22.

    et al. J. Cell Sci. 122, 3169–3179 (2009).

  23. 23.

    et al. Immunogenetics 57, 717–729 (2005).

Download references

Acknowledgements

We thank K. Takahashi, T. Aoi and Y. Yoshida for scientific discussion; M. Narita, T. Ichisaka, M. Ohuchi, M. Nishikawa and N. Takizawa for technical assistance; R. Kato, E. Nishikawa, S. Takeshima, Y. Ohtsu and H. Hasaba for administrative assistance; and H. Niwa (RIKEN) and J. Miyazaki (Osaka University) for the CAG promoter. This study was supported in part by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of National Institute of Biomedical Innovation, a grant from the Leading Project of Ministry of Education, Culture, Sports, Science and Technology (MEXT), a grant from Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program) of Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science and MEXT (to S.Y.) and Senri Life Science Foundation (to K.O.). H.H. is supported by a Japanese government (MEXT) scholarship.

Author information

Affiliations

  1. Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

    • Keisuke Okita
    • , Yasuko Matsumura
    • , Yoshiko Sato
    • , Aki Okada
    • , Asuka Morizane
    • , Hyenjong Hong
    • , Masato Nakagawa
    • , Koji Tanabe
    • , Masayo Takahashi
    • , Jun Takahashi
    •  & Shinya Yamanaka
  2. Department of Biological Repair, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan.

    • Asuka Morizane
    •  & Jun Takahashi
  3. Laboratory for Retinal Regeneration, Center for Developmental Biology, RIKEN, Kobe, Japan.

    • Satoshi Okamoto
    •  & Masayo Takahashi
  4. Department of Tissue and Organ Development, Gifu University Graduate School of Medicine, Gifu, Japan.

    • Ken-ichi Tezuka
    •  & Takahiro Kunisada
  5. Department of Oral and Maxillofacial Science, Gifu University Graduate School of Medicine, Gifu, Japan.

    • Toshiyuki Shibata
  6. Human Leukocyte Antigen (HLA) Laboratory, Kyoto, Japan.

    • Hiroh Saji
  7. Institute for Integrated Cell-Material Sciences, Kyoto University, Kyoto, Japan.

    • Shinya Yamanaka
  8. Yamanaka Induced Pluripotent Stem Cell Project, Japan Science and Technology Agency, Kawaguchi, Japan.

    • Shinya Yamanaka
  9. Gladstone Institute of Cardiovascular Disease, San Francisco, California, USA.

    • Shinya Yamanaka

Authors

  1. Search for Keisuke Okita in:

  2. Search for Yasuko Matsumura in:

  3. Search for Yoshiko Sato in:

  4. Search for Aki Okada in:

  5. Search for Asuka Morizane in:

  6. Search for Satoshi Okamoto in:

  7. Search for Hyenjong Hong in:

  8. Search for Masato Nakagawa in:

  9. Search for Koji Tanabe in:

  10. Search for Ken-ichi Tezuka in:

  11. Search for Toshiyuki Shibata in:

  12. Search for Takahiro Kunisada in:

  13. Search for Masayo Takahashi in:

  14. Search for Jun Takahashi in:

  15. Search for Hiroh Saji in:

  16. Search for Shinya Yamanaka in:

Contributions

K.O. and S.Y. conceived the project and wrote the manuscript. K.O. constructed the vectors with H.H., M.N. and K. Tanabe, and conducted most of the experiments with Y.M., Y. S. and A.O. A.M. and J.T. carried out the differentiation experiment into dopaminergic neurons. S.O. and M.T. performed differentiation into retinal pigment epithelial cells. K. Tezuka., T.S. and T.K. established dental pulp cell lines. H.S. performed HLA haplotyping in Japanese population and supervised HLA analysis.

Competing interests

K.O., M.N. and S.Y. are filing a patent application to Japan, US and EU based on the results reported in this paper (PCT/JP2010/063733). S.Y. is a member of Scientific Advisory Board for iPS Academia Japan Inc. and iPierian Inc., which manage the patents.

Corresponding authors

Correspondence to Keisuke Okita or Shinya Yamanaka.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figures 1–9 and Supplementary Tables 1–7 and 9, 10

Excel files

  1. 1.

    Supplementary Table 8

    Haplotype frequency for HLA-A, HLA-B and HLA-DRB1 loci in Japanese population.